MedTrace Logo

Effect of Cocoa Supplementation and Aerobic Exercise on Pressure Parameters

NCT04732754 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2021-08-20

No results posted yet for this study

Summary

This study evaluates the cocoa supplementation and aerobic exercise on central pressure and arterial stiffness parameters in physically inactive middle-aged individuals.

500mg capsules will be offered to all patients. Of these, half will offer the content of 500mg of cocoa per capsule or placebo capsules. The placebo will contain a pharmacologically inert substance (microcrystalline cellulose) of the same color. A half will start 50' aerobic training 3 times/week while the other half will continue without exercise.

Conditions

  • Sedentary Behavior

Interventions

DIETARY_SUPPLEMENT

Aerobic exercise + Theobroma cocoa (AETC)

Daily consumption of 500mg cocoa in capsules and 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% of VO2peak for 8 weeks.

DIETARY_SUPPLEMENT

Control Group (CG)

Daily consumption of placebo capsules for 8 weeks

DIETARY_SUPPLEMENT

Aerobic Exercise (AE)

Daily consumption of placebo capsules and 3 sessions of physical exercise / week, 50 min / session, with moderate intensity of 50-70% of VO2peak for 8 weeks.

DIETARY_SUPPLEMENT

Theobroma Cocoa (TC)

Daily consumption of 500mg cocoa in capsules for 8 weeks.

Sponsors & Collaborators

  • Instituto de Cardiologia do Rio Grande do Sul

    lead OTHER

Principal Investigators

  • Tainah Ortiz, M.Sc · Instituto de Cardiologia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-01
Primary Completion
2022-09-01
Completion
2022-12-10

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04732754 on ClinicalTrials.gov